Feasibility of generating adeno-associated virus packaging cell lines containing inducible adenovirus helper genes

Journal of Virology

Volumn 76, Issue 4, 2002, Pages 1904-1913

  Qiao, Chunping ^a   Li, Juan ^a   Skold, Anna ^a   Zhang, Xudong ^a   Xiao, Xiao ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; HELICASE; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ADENOVIRUS; ARTICLE; CELL LINE; FEASIBILITY STUDY; GENE INDUCTION; GENE TRANSFER; HUMAN; HUMAN CELL; NONHUMAN; PARVOVIRUS; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; VIRAL CONTAMINATION; VIRUS GENE; VIRUS REPLICATION;

ADENOVIRUS E1A PROTEINS; ADENOVIRUS E1B PROTEINS; CELL LINE; DEPENDOVIRUS; DNA HELICASES; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, VIRAL; GREEN FLUORESCENT PROTEINS; HELA CELLS; HELPER VIRUSES; HUMANS; LUMINESCENT PROTEINS; PARVOVIRIDAE INFECTIONS; PLASMIDS; TRANS-ACTIVATORS; VIRAL PROTEINS; VIRUS ASSEMBLY;

EID: 0036146249     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.4.1904-1913.2002     Document Type: Article

References (41)

1. Adeno-associated virus vectors for gene transfer
2. Adeno-associated viruses: An update
3. Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase
4. Cell lines for the production of recombinant adeno-associated virus
5. Technology evaluation: AAV factor IX gene therapy
6. A cell line for high-yield production of E1-deleted adenovirus vectors without the emergence of replication-competent virus
7. High-titer adeno-associated viral vectors from a Rep/Cap cell line and hybrid shuttle virus
8. Elimination of both E1 and E2 from adenovirus vectors further improves prospects for in vivo human gene therapy
9. Generation of an adenovirus vector lacking E1, E2a, E3, and all of E4 except open reading frame 3
10. Novel tools for production and purification of recombinant adeno-associated virus vectors
11. Progress in adeno-associated virus type 2 vector production: Promises and prospects for clinical use
12. A simplified system for generating recombinant adenoviruses
13. Colocalization of adeno-associated virus Rep and capsid proteins in the nuclei of infected cells
14. Packaging cells based on inducible gene amplification for the production of adeno-associated virus vectors
15. Adeno-associated viral vector-mediated gene transfer results in long-term enzymatic and functional correction in multiple organs of Fabry mice
16. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector
17. Role for highly regulated rep gene expression in adeno-associated virus vector production
18. Production of recombinant adeno-associated virus vectors using a packaging cell line and a hybrid recombinant adenovirus
19. Steroid receptor coactivator-1 (SRC-1) enhances ligand-dependent and receptordependent cell-free transcription of chromatin
20. Adeno-associated virus vectors can be efficiently produced without helper virus
21. Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia
22. Use of adeno-associated virus as a general transduction vector for mammalian cells
23. Factors influencing recombinant adeno-associated virus production
24. Helper-free stocks of recombinant adeno-associated viruses: Normal integration does not require viral gene expression
25. Adeno-associated viral vectors
26. Diverse strategies for tetracyclineregulated inducible gene expression
27. A new strategy for large-scale preparation of high-titer recombinant adeno-associated virus vectors by using packaging cell lines and sulfonated cellulose column chromatography
28. Exploring the sequence space for tetracycline-dependent transcriptional activators: Novel mutations yield expanded range and sensitivity
29. Analysis of recombinant adeno-associated virus packaging and requirements for rep and cap gene products
30. Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus
31. Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model
32. Sustained expression of therapeutic level of factor IX in hemophilia B dogs by AAV-mediated gene therapy in liver
33. Adeno-associated virus as a vector for liver-directed gene therapy
34. Adeno-associated virus (AAV) vectors for gene transfer
35. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector
36. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus
37. Full functional rescue of a complete muscle (TA) in dystrophic hamsters by adeno-associated virus vector-directed gene therapy
38. Characterization of cell lines that inducibly express the adeno-associated virus Rep proteins
39. Regulated delivery of therapeutic proteins after in vivo somatic cell gene transfer